Investment company Mayo Clinic (Current Portfolio) buys Cancer Genetics Inc, sells ClearPoint Neuro Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Mayo Clinic. As of 2020Q1, Mayo Clinic owns 6 stocks with a total value of $39 million. These are the details of the buys and sells.
Here is the complete portfolio of Mayo Clinic. Also check out:
1. Mayo Clinic's Undervalued Stocks
2. Mayo Clinic's Top Growth Companies, and
3. Mayo Clinic's High Yield stocks
4. Stocks that Mayo Clinic keeps buying
For the details of Mayo Clinic's stock buys and sells, go to https://www.gurufocus.com/guru/mayo+clinic/current-portfolio/portfolio
These are the top 5 holdings of Mayo Clinic- Black Stone Minerals LP (BSM) - 5,711,137 shares, 69.37% of the total portfolio. Shares added by 0.23%
- Unity Biotechnology Inc (UBX) - 1,571,981 shares, 23.66% of the total portfolio.
- Evelo Biosciences Inc (EVLO) - 484,953 shares, 4.73% of the total portfolio.
- Seres Therapeutics Inc (MCRB) - 180,000 shares, 1.67% of the total portfolio.
- Exact Sciences Corp (EXAS) - 3,795 shares, 0.57% of the total portfolio.
Mayo Clinic initiated holding in Cancer Genetics Inc. The purchase prices were between $2.09 and $5.96, with an estimated average price of $4.11. The stock is now traded at around $2.96. The impact to a portfolio due to this purchase was less than 0.01%. The holding were 444 shares as of .
Sold Out: ClearPoint Neuro Inc (CLPT)Mayo Clinic sold out a holding in ClearPoint Neuro Inc. The sale prices were between $3.33 and $6.14, with an estimated average price of $4.94.
Here is the complete portfolio of Mayo Clinic. Also check out:
1. Mayo Clinic's Undervalued Stocks
2. Mayo Clinic's Top Growth Companies, and
3. Mayo Clinic's High Yield stocks
4. Stocks that Mayo Clinic keeps buying
